The role of SERCA in vascular diseases, a potential therapeutic target
Cell Calcium · 2025
DOI: 10.1016/j.ceca.2025.103039 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Calcium, 2025. Verfasst von Qinghua Yu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Cardiology, The First Hospital of China Medical University, China. Hauptthemen laut MEDLINE: Sarcoplasmic Reticulum Calcium-Transporting ATPases, Vascular Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 105 Literaturangaben.
Abstract (Originalsprache)
SERCA, the sarco/endoplasmic reticulum Ca2+-ATPase, is a pivotal protein that transports calcium ions (Ca2+) from the cytoplasm into the sarcoplasmic/endoplasmic reticulum (SR/ER), thus sustaining cellular Ca2+ homeostasis. A growing body of evidence indicates that SERCA dysfunction correlates with disrupted cellular Ca2+ homeostasis and ER stress, precipitating a spectrum of chronic diseases. As a regulator of Ca2+ homeostasis, SERCA emerges as a potential therapeutic target for conditions associated with Ca2+ imbalance. This review delineates the association between SERCA and a variety of vascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatric Cardiology, The First Hospital of China Medical University, China.
- Department of Geriatric Cardiology, The First Hospital of China Medical University, China. Electronic address: wtian56@cmu.edu.cn.
Zitieren
APA
Yu, Q., & Tian, W. (2025). The role of SERCA in vascular diseases, a potential therapeutic target. Cell Calcium. https://doi.org/10.1016/j.ceca.2025.103039
Vancouver
Yu Q, Tian W. The role of SERCA in vascular diseases, a potential therapeutic target. Cell Calcium. 2025. doi:10.1016/j.ceca.2025.103039
BibTeX
@article{Yu2025,
author = {Yu, Qinghua and Tian, Wen},
title = {The role of SERCA in vascular diseases, a potential therapeutic target},
journal = {Cell Calcium},
year = {2025},
doi = {10.1016/j.ceca.2025.103039}
}
EUVIMED